Real-world data is increasingly used to optimize trial design, reduce recruitment burden, and support regulatory decisions, but adoption remains uneven due to challenges around data quality, ...

Theriva Biologics has received FDA agreement on the core design elements of a pivotal phase 3 trial evaluating zabilugene ...

A study evaluates disinfectants for decontaminating dropped implants in surgery, highlighting risks and the efficacy of CHG ...

Stakeholders responding to recent draft guidance from the US Food and Drug Administration (FDA) on the use of minimal ...

This narrative review examines evidence linking Attention-Deficit/Hyperactivity Disorder (ADHD) and long-term brain health, ...

Trial shows fewer HF hospitalizations in HFpEF ...

Dietary fiber supplementation shows potential in managing blood sugar levels and preventing preterm births in pregnancies at ...

A growing body of experimental research suggests that using ChatGPT can boost short-term performance on some tasks, but may ...

Switching from INSTI-based ART to a DOR-based regimen does not lead to clinically meaningful weight loss in adults with HIV and obesity.

Angioplasty with sirolimus-coated balloons, as compared with uncoated balloons, reduced limb amputation and other adverse ...

Clinical trials are losing participants. Patient-first design and decentralized models can help fix the dropout problem.

The results run counter to ABYSS but align with other data showing beta-blockers shouldn’t continue indefinitely after MI.